|
|
|
|
| LEADER |
00000cam a22000003i 4500 |
| 001 |
EBOOKCENTRAL_on1287023056 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
211202s2016 xx o 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d YDX
|d IDB
|d MERUC
|d OCLCF
|d COCUF
|d STF
|d LOA
|d CUY
|d ZCU
|d ICG
|d K6U
|d VT2
|d U3W
|d WYU
|d LVT
|d TKN
|d DKC
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 961933992
|a 962156370
|a 1055363848
|a 1066459754
|a 1081240245
|a 1107363569
|a 1228528165
|
| 020 |
|
|
|a 9788897419648
|q (electronic bk.)
|
| 020 |
|
|
|a 889741964X
|q (electronic bk.)
|
| 020 |
|
|
|z 9788897419631
|
| 020 |
|
|
|a 8897419631
|
| 020 |
|
|
|a 9788897419631
|
| 035 |
|
|
|a (OCoLC)1287023056
|z (OCoLC)961933992
|z (OCoLC)962156370
|z (OCoLC)1055363848
|z (OCoLC)1066459754
|z (OCoLC)1081240245
|z (OCoLC)1107363569
|z (OCoLC)1228528165
|
| 050 |
|
4 |
|a HD9665.5
|b .P437 2016eb
|
| 060 |
|
4 |
|a 2017 H-887
|
| 060 |
|
4 |
|a QV 736.1
|
| 082 |
0 |
4 |
|a 338.476151
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Koçkaya, Güvenç.
|
| 245 |
1 |
0 |
|a Pharmaceutical Market Access in Emerging Markets.
|
| 264 |
|
1 |
|a [Place of publication not identified] :
|b SEEd srl :
|b SEEd,
|c 2016.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Vendor-supplied metadata.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Cover ; Colophon ; Preface; 1. Introduction to the Market Access; 1.1 Origin of the Market Access term; Market Access for goods; Application of the Market Access concept to healthcare: similarities with market economy; 1.2 Healthcare market specifics; 1.3 Market Access definition; 1.4 Market Access key concepts; What is Access; What is Value; Market Access and the structure of healthcare market; 1.5 Cultural specificities of Market Access; 1.6 Market Access from payers perspective; The payers of healthcare; Market Access tools to control drug expenditure; The Value assessment by payers.
|
| 505 |
8 |
|
|a The link between HTA and Pricing & Reimbursement conditionsNon-HTA tools that affect pricing; 1.7 Market Access Agreements; Definition; Taxonomy; The future; 1.8 References; 1.9 To know more; 2. Market Access in Asian countries; 2.1 Overview on the Healthcare Systems and Healthcare Policies; South Korea; China; Thailand; 2.2 Recent Healthcare Policies; Thailand; South Korea; China; 2.3 Pathways of Market Access; South Korea; China; Thailand; 2.4 Challenges and catalyzers for Market Access; 2.5 Market Outlook; 2.6 References; 2.7 To know more; 3. Market Access in South American Countries.
|
| 505 |
8 |
|
|a 3.1 Introduction3.2 General economic outlook; 3.3 Health Sector; 3.4 Pharmaceutical Markets; 3.5 Health Technology Agencies; The History of HTA in Latin America; Red ETSA -- Pan-American Health Organization (PAHO/WHO); How the future looks? ; 3.6 Market access; Mexico; Colombia; Access to Mexico; Access to Colombia; 3.7 Final Comments; 3.8 To know more; 4. Market Access in South Eastern Europe Countries; 4.1 Introduction; Historical influence and heritage of healthcare sector; 4.2 General Outlook of Healthcare System and Health Policies; Albania; Bosnia and Herzegovina; Kosovo; Macedonia, FYR.
|
| 505 |
8 |
|
|a MontenegroSerbia; 4.3 Pathways of Market Access (Regulation and Reimbursement); Albania; Kosovo; 4.4 Mapping and structure of Decision Makers; Albania; Bosnia and Herzegovina; Macedonia, FYR; Montenegro; Serbia; 4.5 Challenges and catalyzers for Market Access and Look-up for Near Future; Albania; Bosnia and Herzegovina; Kosovo; Macedonia, FYR; Montenegro; Serbia; 4.6 References; 5. Market Access in North Eastern Europe Countries; 5.1 General Outlook of Healthcare System and Health Policies; Russia; Poland; Ukraine; 5.2 Pathways of Market Access; Russia; Poland; Ukraine.
|
| 505 |
8 |
|
|a 5.3 Mapping and Structure of Decision MakersRussia; Poland; Ukraine; 5.4 Challenges and Catalyzers for Market Access; Russia; Poland; Ukraine; 5.5 Good Examples from Successful Market Access Strategies; Russia; Poland; Ukraine; 5.6 Look up for near future; Russia; Poland; Ukraine; 5.7 References; 6. Market Access in the United Arab Emirates and Selected Middle Eastern Countries; 6.1 The Middle East; The Gulf Cooperation Council; 6.2 Introduction; 6.3 General Outlook of Healthcare System and Health Policies in the UAE and Other ME Countries; The United Arab Emirates (UAE).
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Drugs
|x Marketing.
|
| 650 |
1 |
2 |
|a Drug Industry
|x economics
|
| 650 |
1 |
2 |
|a Marketing
|x economics
|
| 650 |
2 |
2 |
|a Costs and Cost Analysis
|
| 650 |
2 |
2 |
|a Pharmaceutical Preparations
|x economics
|
| 650 |
2 |
2 |
|a Internationality
|
| 650 |
|
7 |
|a Drugs
|x Marketing
|2 fast
|
| 700 |
1 |
|
|a Wertheimer, Albert.
|
| 758 |
|
|
|i has work:
|a Pharmaceutical market access in emerging markets (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGF4cHg4kfFdGVjfpg7Rw3
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Koçkaya, Güvenç.
|t Pharmaceutical Market Access in Emerging Markets.
|d Turin : SEEd Medical Publishers, ©2016
|z 9788897419631
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5316193
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2207074
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL5316193
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13239508
|
| 994 |
|
|
|a 92
|b IZTAP
|
